The pharma major has entered into a partnership with Bayer to market and distribute a second brand of Vericiguat in India. Under the terms of this agreement, Bayer has granted non-exclusive rights to Dr. Reddys under the brand name Gantra. Vericiguat is used in the treatment of chronic heart failure with a reduced ejection fraction.
MARKET VIEW
OUTLOOK
SECTORS
STRATEGY
VIEW
PERSONAL FINANCE
INSURANCE
INVEST
MUTUAL FUND
GENERAL